What is the market doing?
What the tape says about IMVT
Immunovant, Inc. is +179% over the past year while the S&P 500 is +23%: 157 points ahead of the market.
+179%
1-year return · S&P 500 +23%
- vs 200-day average
- +52%
vs 200-day average · a clear uptrend
- RSI (14)
- 72
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −2.4%
Below its 52-week high
Details›
- Last close2026-08-26
- $43.90
- 1 monthS&P 500 +3.7%
- +11%
- 1 yearS&P 500 +23%
- +179%
- 5 yearsS&P 500 +87%
- +467%
- vs 50-day average$38.19
- +15%
- 52-week high
- $45.00
- 52-week low
- $14.69
- Annualised volatility
- 57%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$13M
| Year | Return |
|---|---|
| 2026 (year to date) | +73% |
| 2025 | +2.6% |
| 2024 | −41% |
| 2023 | +137% |
| 2022 | +108% |
| 2021 | −82% |
| 2020 | +191% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 2 of 7 | −8.2% |
| Feb | 7 | 1 of 7 | −12% |
| Mar | 7 | 1 of 7 | −6.9% |
| Apr | 7 | 3 of 7 | −0.94% |
| May | 7 | 3 of 7 | +9.2% |
| Jun | 7 | 3 of 7 | −3.8% |
| Jul | 8 | 5 of 8 | +3.8% |
| Aug | 8 | 5 of 8 | +8.6% |
| Sep | 7 | 6 of 7 | +12% |
| Oct | 7 | 5 of 7 | +23% |
| Nov | 7 | 4 of 7 | +5.9% |
| Dec | 7 | 5 of 7 | +13% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.